Jupiter Topco LLC Acquires Shares of 82,200 DENTSPLY SIRONA Inc. $XRAY

Posted by on Sep 6th, 2026

Jupiter Topco LLC acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 82,200 shares of the medical instruments supplier’s stock, valued at approximately $872,000.

A number of other institutional investors have also modified their holdings of the stock. Hsbc Holdings PLC acquired a new position in shares of DENTSPLY SIRONA in the second quarter valued at approximately $464,000. Canada Pension Plan Investment Board purchased a new position in DENTSPLY SIRONA in the 2nd quarter valued at $271,000. Legal & General Group Plc purchased a new position in DENTSPLY SIRONA in the 2nd quarter valued at $3,249,000. The Manufacturers Life Insurance Company acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at $1,956,000. Finally, Paradigm Capital Management Inc. NY purchased a new position in DENTSPLY SIRONA during the 2nd quarter worth $39,775,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Michael Barber purchased 15,175 shares of DENTSPLY SIRONA stock in a transaction dated Thursday, June 11th. The stock was bought at an average cost of $9.88 per share, for a total transaction of $149,929.00. Following the transaction, the director owned 55,943 shares in the company, valued at approximately $552,716.84. The trade was a 37.22% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Brian McKeon purchased 10,000 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were purchased at an average cost of $10.12 per share, for a total transaction of $101,200.00. Following the purchase, the director directly owned 10,000 shares in the company, valued at approximately $101,200. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders purchased 35,160 shares of company stock valued at $351,179. Corporate insiders own 0.46% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Barclays raised their target price on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th. BMO Capital Markets reissued a “market perform” rating and set a $13.00 price target on shares of DENTSPLY SIRONA in a report on Friday, August 7th. Piper Sandler raised their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. Barrington Research set a $15.00 price objective on DENTSPLY SIRONA in a report on Monday, August 10th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $13.54.

View Our Latest Stock Report on XRAY

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $11.38 on Friday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. DENTSPLY SIRONA Inc. has a one year low of $9.40 and a one year high of $14.86. The firm has a market capitalization of $2.27 billion, a P/E ratio of -4.14, a PEG ratio of 1.45 and a beta of 0.84. The company’s fifty day moving average is $12.16 and its two-hundred day moving average is $11.67.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The business had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. During the same quarter last year, the firm posted $0.52 EPS. The business’s revenue was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current fiscal year.

About DENTSPLY SIRONA

(Free Report)

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.